3rd Annual Risk-Sharing and Innovative Contracting Models for Bio/Pharmaceuticals

Philadelphia, PA — www.cbinet.com

CBI’s 3rd Annual Risk-Sharing and Innovative Contracting Models provides an opportunity for updates and continued conversation on the strategic implications for pharma and biotech manufacturers when entering into risk-sharing agreements.
 
Since payers and manufacturers have recognized that these agreements are the future of contracting in highly populated therapeutic areas and for treatment of chronic conditions, it is critical to learn how to best apply these agreements for optimum success.